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Abstract
KATP channels in the vasculature composed of Kir6.1 regulate vascular tone and may contribute to the pathogenesis of
endotoxemia. We used mice with cell-specific deletion of Kir6.1 in smooth muscle (smKO) and endothelium (eKO) to inves-
tigate this question. We found that smKO mice had a significant survival disadvantage compared with their littermate controls
when treated with a sub-lethal dose of lipopolysaccharide (LPS). All cohorts of mice became hypotensive following bacterial
LPS administration; however, mean arterial pressure in WT mice recovered to normal levels, whereas smKO struggled to
overcome LPS-induced hypotension. In vivo and ex vivo investigations revealed pronounced cardiac dysfunction in LPS-
treated smKO, but not in eKO mice. Similar results were observed in a cecal slurry injection model. Metabolomic profiling of
hearts revealed significantly reduced levels of metabolites involved in redox/energetics, TCA cycle, lipid/fatty acid and amino
acid metabolism. Vascular smooth muscle-localised KATP channels have a critical role in the response to systemic infection by
normalising cardiac function and haemodynamics through metabolic homeostasis.
Key messages
• Mice lacking vascular KATP channels are more susceptible to death from infection.
• Absence of smooth muscle KATP channels depresses cardiac function during infection.
• Cardiac dysfunction is accompanied by profound changes in cellular metabolites.
• Findings from this study suggest a protective role for vascular KATP channels in response to systemic infection.
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Introduction
Endotoxemia is a component of the pathophysiology of gram-
negative sepsis though the relative clinical importance is
contentious [1]. The administration of lipopolysaccharide in
animals results in hypotension and increased mortality. The
role of KATP channels in endotoxemia is unclear. Initially,
KATP channel hyperactivity was thought to contribute to the
profound hypotension seen in patients with endotoxemia.
KATP channels are K
+ selective ion channels that respond to
and are regulated by changes in the metabolic status (changes
in the ATP/ADP ratio) of the cell. They are expressed in many
tissues and play a critical role in coupling cellular metabolism
to membrane excitability. Functional KATP channels are com-
posed of a hetero-octomeric complex of 4 pore-forming sub-
units (Kir6.1 or Kir6.2) and 4 SURs (SUR1, SUR2A or
SUR2B) [2]. These channels have a tissue-specific subunit
composition at the molecular level with characteristic pharma-
cological profiles. For example, the vascular smooth muscle
(VSM) channel is comprised of Kir6.1 and SUR2B [3, 4]. In
VSM, KATP channels regulate vessel tone and therefore blood
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pressure by opening or closing in response to vasoactive sub-
stances such as adenosine or noradrenaline and/or metabolic
stress such as ischaemia. Opening of the channel leads to
membrane hyperpolarisation, closure of voltage-dependent
Ca2+ channels (VDCC) and subsequent relaxation [2, 3, 5].
Studies in animal models of endotoxic shock, where the
KATP blocker glibenclamide reversed an LPS-induced drop
in arterial blood pressure, support the hypothesis that hypo-
tension may be due to increased KATP channel activity [6–8].
Furthermore, vessels from LPS-treated rodents show in-
creased vascular hypo-reactivity and expression of Kir6.1
and SUR2B [6, 9]. However, evidence from transgenic mice
has revealed that KATP may in fact be protective during infec-
tion. For example, global deletion of Kir6.1 in mice results in a
poor survival outcome following LPS exposure [10].
Furthermore, survival rates of WT mice are improved by the
pharmacological activation of KATP [10, 11]. Interestingly, the
protective nature of KATP channels against infection is pre-
served across species, for example in insects where suppres-
sion and activation of KATP is detrimental and protective, re-
spectively [11, 12]. Endotoxemia and sepsis lead to patholog-
ical changes in metabolism with increased metabolic demand
and a highly catabolic state [1, 13]. Studies investigating KATP
channels in endotoxemia-induced myocardial metabolic
changes are lacking.
Though the studies in the global knockout mice are re-
vealing, their interpretation is complicated by a number of
factors. Kir6.1 is known to be ubiquitously expressed in
many cells and tissues in addition to VSM. Evidence from
mice with conditional deletion of Kir6.1, in endothelium
and cardiac tissues, reveals important physiological func-
tions complicating the understanding of pathophysiologi-
cal data from the global knockout mouse [14, 15]. In addi-
tion, global Kir6.1 KO mice are prone to unprovoked sud-
den death resulting in technical and interpretive issues.
Furthermore, there is pharmacological evidence that drugs
acting on KATP channels can modulate immune cell func-
tion [16]. In general, evidence for a direct tissue-specific
role of the vascular KATP channel in endotoxemia is scarce.
In this study, we have investigated the role of vascular
(smooth muscle and endothelial) KATP channels in re-
sponse to endotoxic shock using cell-specific and global
Kir6.1 KO mice. We delineate the role of VSM KATP chan-
nels in preserving cardiac metabolism during endotoxin-
induced shock.
Materials and methods
Animal husbandry
All experiments were conducted in accordance with the Guide
for the Care and Use of Laboratory Animals published by the
British Home Office regulations, in accordance with the EU
Directive 2010/63/EU, and by the US National Institutes of
Health (NIH Publication No. 85-23, revised 1996).
Endotoxemia and cecal slurry
We used 2 models of endotoxemia/sepsis—administration of
lipopolysaccharide (LPS, Sigma-Aldrich) [17, 18] and cecal
slurry (CS) from C57/B6 mice [19]. LPS was used at a dose of
10 mg/kg (I.P) for the blood pressure and survival studies and
was reduced to 2 mg/kg (with 0.1 mg/kg peptidoglycan) for
further studies. The CS model involved causing infection by
administering faecal matter extracted and purified from the
cecum of C57\B6 mice. The CSmix was made by suspending
the faecal matter from 2 to 3 C57/B6 mice in water and filter-
ing through a 100-μm filter and then 80-μm filter. A total of
150 μL was injected per mouse 20 h prior to experimental
study.
Echocardiography
In vivo cardiac function and morphology were assessed by M-
mode echocardiography conducted under anaesthesia (induced
at 3% andmaintained at 1.5% isoflurane, body temperature was
monitored and maintained at 37 °C via a rectal thermometer).
Echocardiography was performed using a VisualSonics Vevo
770 or 3100 imaging system (VisualSonics, Toronto, Canada).
Short-axis M-mode images were acquired for analysis to pro-
vide heart chamber dimensions and calculate percentage frac-
tional shortening.
Details of the methods for BP telemetry, mouse generation
and genotyping, quantification of renal dysfunction and liver
damage, isolated heart experiments, TUNEL assay, 1H-NMR
metabolomics and data analysis can be found in the supple-
mentary information.
Results
Kir6.1 KO mice have sustained hypotension and
survival disadvantage following LPS-induced endo-
toxic shock
In response to a sub-lethal dose of LPS, all genotypes of mice
showed signs of endotoxemia including decreased activity,
piloerection and periocular discharge. WT mice were more
tolerant to LPS than Kir6.1 KO mice (Fig. 1a). The majority
of WT (2/13 died) mice survived the sub-LPS insult with no
deaths before 24 h. Mice lacking Kir6.1 in smooth muscle,
smKO (5/12,P < 0.05 comparedWT) and, globally, gKO (15/
16, P < 0.001 and P < 0.05 compared with WT and smKO
respectively) were more predisposed to LPS-induced mortal-
ity (all mice on a C57Bl\6 background). Global KO mice
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started to die within 3 h of LPS administration with 60% of
deaths occurring by 18 h and less than 10% surviving at 48 h.
In the smKO cohort, mice had an improved long-term survival
outcome compared with gKO but worse than WT mice with
the majority of deaths occurring after 24 h. These data suggest
an important role for vascular KATP channels in the response
to endotoxic shock. There were no deaths of untreated mice
over the same time period (data not shown).
LPS-induced hypotension persists in Kir6.1 KO mice
We used blood pressure radio-telemetry to investigate the
haemodynamic effects of LPS in WT, smKO and gKO
mice (Fig. 2). Changes in mean arterial pressure (MAP)
were monitored in conscious freely moving animals for
up to 42 h dependent on animal health and telemetry signal
integrity—gKO mice with implanted probes did not sur-
vive past 24 h. All cohorts of mice became hypotensive
following intraperitoneal administration of LPS (Fig. 2a
and c). Initial hypotension (up to 15 h) was more pro-
nounced in WT mice than in both Kir6.1 KO cohorts
(WT: ~ 61%, smKO: ~ 43% and gKO: ~ 36%, Fig. 2a and
c). Furthermore, in WT mice, MAP returned to baseline by
the conclusion of the telemetry recordings. However, in
smKO mice, hypotension was sustained. In mice with
global deletion of Kir6.1, the drop in MAP was similar to
both WT and smKO mice at 24 h (Fig. 2). These data
support a role for KATP channels in the recovery from hy-
potension during endotoxemia. There was also a signifi-
cant drop in heart rate (HR) in all 3 cohorts (Fig. 2a and
c). In WT mice, HR recovered quickly from 15 h post-LPS
insult to reach baseline levels. Conversely, in smKO and
gKO mice, the drop in HR was sustained suggesting a
substantial detrimental change in cardiac function.
smKOmice have severe cardiac dysfunction following
LPS-induced endotoxic shock
Eighteen hours post-LPS administration, in vivo cardiac func-
tion was assessed in smKOmice and their littermates by echo-
cardiography. It showed a dramatic reduction in ejection frac-
tion (EF) in smKO mouse hearts (~ 20% compared with ~
70% in WT hearts, P < 0.05). Left ventricular end-diastolic
volume (LVEDV) and left ventricular internal dimensions
(LVID) were also significantly increased (Fig. 3, P < 0.01).
In addition, fractional shortening (FS) and fractional area
change (FAC) were also compromised suggesting progression
towards LV failure in smKO mice (Fig. 3, P < 0.01). To as-
certain if cardiac dysfunction was as a result of cell apoptosis,
we used the TUNEL assay on heart sections from WT and
smKO LPS-treated mice (Fig. 3c). Hearts from smKO mice
showed significantly more cell death compared with WT
littermates.
To confirm the critical role of KATP in response to infec-
tion, we used the CS model. All mice showed outward signs
of infection such as piloerection and lethargy following CS
administration. Echocardiography revealed a less severe car-
diac phenotype compared with LPS mice; however, EF, FS
and FAC were significantly reduced in smKO mice (Fig. 4).
These data provide further evidence that smKOmice are more
susceptible to cardiac dysfunction when subjected to
endotoxemia and potentially sepsis. Baseline echocardiogra-
phy parameters were similar inWT and smKOmice (Fig. S1).
We investigated LV function further using the Langendorff
isolated heart method (Fig. 5). Isolated hearts (18 h post-LPS)
from WT and smKO mice were retrogradely perfused and
HR, coronary perfusion pressure (CPP) and LV pressure mea-
sured. HR was lower and CPP higher in smKO mouse hearts
compared with control hearts, although this was not statisti-
cally significant. Interestingly, LV end-diastolic pressure
(LVEDP) was increased 3-fold in smKO hearts (P < 0.01).
Furthermore, LV developed potential (peak systolic pres-
sure–end-diastolic pressure) (LVDP) was significantly re-
duced in smKO hearts (P < 0.001). These data show a signif-
icantly reduced LV compliance in LPS-treated smKO hearts.
Furthermore, in smKO hearts, the pressure-volume relation-
ships were uncoupled with increasing pre-load of the LV. The
LV of smKO hearts had reduced compliance with increased
volumes as reflected in the significantly enhanced LVEDP
and this occurred together with a minimal change in LVDP
(P < 0.001). Overall, these data indicate increased LV stiffness
leading to reduced compliance and impaired developed pres-
sure at a given LV volume.
If left untreated, endotoxic shock can lead to multi-organ
dysfunction. We investigated possible multi-organ dysfunc-
tion by analysing blood markers of kidney dysfunction and
liver damage 18 h post-LPS. There was no difference in the
levels of the kidney damage markers, urea and creatinine in
Fig. 1 Mice lacking Kir6.1 are predisposed to an increase risk of LPS-
induced death. WT, smKO and gKO mice were dosed with 10 mg/kg
LPS (I.P injection) and monitored for 24–48 h. a Kaplan-Meier survival
curves for mice (WT-black line, smKO-grey line and gKO-dotted line)
treated with LPS. Differences between curves was assessed using the log-
rank (Mantel-Cox) test, *P < 0.05, ***P < 0.001 compared with WT,
#P < 0.01 compared with smKO. b Proportion of death/survival after
LPS administration for each genotype over a 48-h period. n = 12–16mice
per group. Fisher’s exact test was used to for statistical analysis,
*P < 0.05, ***P < 0.001
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Fig. 2 WT and Kir6.1 KO mice are susceptible to severe hypotension
following LPS treatment. a Representative mean arterial pressure (MAP)
traces from blood pressure telemetry recordings fromWT, smKO and gKO
mice following I.P injection of 10 mg/kg LPS. b Representative heart rate
traces derived from blood pressure telemetry recordings from WT, smKO
and gKO mice injected with LPS. cMean relative MAP (left), mean MAP
at baseline (middle) and % drop in MAP at 15 and 18 h post-LPS (right)
(n = 5–8 mice for each group). dMean relative heart rate (left), mean heart
rate at baseline (middle) and% change in heart rate at 15 and 18 h post-LPS
(n = 5–8 mice for each group). In c and d, data is shown as mean ± SEM.
*P < 0.05, **P0.01 (unpaired Student’s t test and 2-way ANOVA).
#P < 0.05, ##P < 0.01 compared with baseline (unpaired Student’s t test)
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Fig. 3 Cardiac function is substantially reduced in smKOmice following
LPS administration. a Mean body temperature and echocardiography
parameter measurements from smKO mice and their littermate controls
18 h post-LPS injection (2 mg/kg I.P). Ejection fraction (EF), fractional
shortening (FS), left ventricular end-diastolic volume (LVEDP) and left
ventricular internal diameter (LVID) were derived from short-axis M-
mode images. Fractional area change (FAC) was measured from short-
axis B-mode images (n = 5–6 mice per group). b Levels of circulating
markers for kidney (urea and creatinine) and liver (ALT-alanine
acetyltransferase) damage in the blood of smKOmice and their littermate
controls (n = 5–6 mice per group). c Representative images (left) and
mean cell death (right) from a TUNEL assay on sections from smKO
(n = 4) and littermate control (n = 4) hearts. Data is shown as mean ±
S.E.M, *P < 0.05, **P < 0.01, ***P < 0.001 (unpaired Student’s t test)
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smKO mice and their littermates (Fig. 3). Liver function was
compromised in smKO mice as reflected in the increased
levels of alanine aminotransferase (P < 0.01, Fig. 3). In the
CS model, there was no difference in these markers (Fig. 4).
These data suggest that during endotoxemia, the absence of
Kir6.1 in VSM does not detrimentally affect kidney function
but may lead to modest liver dysfunction.
eKO mice do not show a significant decrease in
cardiovascular function
The phenotype of gKO mice following LPS treatment was
comparatively more severe than in smKO mice. Kir6.1-con-
taining KATP channels are also expressed in vascular endothe-
lium [15]. To investigate if a more severe phenotype was due
to the additional absence of Kir6.1 in endothelium in gKO
mice, we subjected endothelium-specific Kir6.1 KO mouse
(eKO) and their littermate controls to echocardiography 18 h
post-LPS administration. We found that eKO mice are less
prone to cardiac dysfunction compared with smKO mice. EF
was reduced by ~ 15%; however, this was not significant (P =
0.35, Fig. 6). There was also a trend, albeit not significant
towards an increase in kidney and liver damage markers.
Taken together, these data suggest that Kir6.1-containing
KATP channels in endothelium make little or no contribution
to the cardiac dysfunction in endotoxemia.
High-resolution metabolomic profiling using 1H NMR
spectroscopy
Altered myocardial metabolism has been described in septic
patients and animal models of endotoxemia and sepsis
[20–22]. To test for changes in metabolites in hearts from
WT and smKO LPS-treated mice, we used 1H NMR spectros-
copy (Fig. 7). The metabolomic profile shows a clear and
significant change in cardiac tissue from smKO mice com-
pared with littermate controls (Fig. 7). Metabolites involved
in redox and energetics of cardiac cells were significantly
lower in smKO mice compared with WT. Specifically, key
components of intracellular energetics ATP, phosphocreatine
Fig. 4 Cardiac function is reduced in smKO mice following sepsis
induced by cecal slurry administration. a Mean body temperature and
echocardiography parameter measurements from smKO mice and their
littermate controls 20 h post-cecal slurry injection. Ejection fraction (EF),
fractional shortening (FS), left ventricular end-diastolic volume (LVEDP)
and left ventricular internal diameter (LVID) were derived from short-
axis M-mode images. Fractional area change (FAC) was measured from
short-axis B-mode images (n = 6 mice for each group). b Levels of cir-
culating markers for kidney (urea and creatinine) and liver (ALT-alanine
acetyltransferase) damage in the blood of smKOmice and their littermate
controls (n = 6 mice for each group). Data is shown as mean ± S.E.M,
*P < 0.05, **P < 0.01, ***P < 0.001 (unpaired Student’s t test)
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and creatine were drastically reduced (2-, 1.7- and 5-fold,
respectively) suggestive of severe metabolic compromise.
The TCA intermediates, fumarate (~ 6.7-fold) and succinate
(~ 2.7-fold) are also significantly lower in smKO LPS-treated
hearts suggesting enhanced TCA cycle flux. Additionally, the
levels of a number of amino acids (aspartate, glutamine, glu-
tamate, glycine and taurine) are reduced by ~ 50% suggesting
increased utilization of amino acids, a hallmark of a metabol-
ically stressed state. Depletion of acetyl carnitine suggests
increased lipolysis. Overall, these data show profound chang-
es in the levels of cellular metabolites in LPS-treated smKO
hearts and is likely to be detrimental to the functional recovery
from endotoxemia.
Discussion
The role of KATP channels in endotoxic shock is poorly un-
derstood with a debate as to whether their activation is detri-
mental or beneficial. The investigation of the pathophysiology
is complicated by the broad expression of channel subunits in
a number of relevant tissues. In this study, we show novel data
that indicates a major component of the pathophysiology
resides in the vascular KATP channel and resulting cardiac
dysfunction due to profound impairment of cardiac metabo-
lism and cellular apoptosis. A plausible scenario is that the
vascular KATP channel matches metabolic demand and perfu-
sion during an endotoxic challenge, and this is particularly
critical in the coronary circulation. Our proposed mechanism
is shown in Fig. 8.
KATP channels and endotoxemia
Earlier studies have identified KATP channels as playing a role
in the pathogenesis of endotoxemia [7, 10, 11]. In particular, it
was postulated that KATP channels are involved in the devel-
opment of severe hypotension and possibly resistance to va-
sopressors during endotoxemia [9]. Following convention,
one would expect endotoxemia-induced hypotension to be
less or not as severe in mice where KATP is absent and this
has been shown in a previous study using Kir6.1 global KO
mice [10]. The interpretation of this work is complicated by
the expression of Kir6.1 subunits in a number of tissues [14,
15]. Herein, we observed a substantial drop in MAP, almost
equivalent toWT, in our global and smoothmuscle Kir6.1 KO
mice (Fig. 2). Hypotension in Kir6.1 KO mice due to
Fig. 5 Cardiac function is severely perturbed in isolated LPS-treated
smKO mouse hearts. Hearts were isolated from mice 18 h post-LPS
administration (2 mg/kg I.P) and mounted via the aorta on to a
Langendorff apparatus and retrogradely perfused to investigate coronary
function and LV function. Mean HR (a), coronary perfusion pressure
(CPP) (b), left ventricular end-diastolic pressure (LVEDP) (c) and left
ventricular developed potential (LVDP) (d) measured from isolated
hearts of smKO and littermate control mice 18 h post-LPS administration.
Starling curves for LVDP (e) and LVEDP (f). Data is shown as mean ±
S.E.M, n = 5 mice for each group, **P < 0.01, ***P < 0.001 (unpaired
Student’s t test and 2-way ANOVA)
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endotoxic shock is perhaps not entirely surprising as a number
of K+ channels other than KATP channels can also regulate
membrane potential and therefore vascular tone. Indeed, this
has been shown in the context of sepsis where BKCa, Kir and
Kv channels have all been shown to increase resting mem-
brane potential in aorta of a rat model of septic shock [23].
KATP, however, is likely to be a component involved in hy-
potension as the drop in MAP was greater/quicker at 15 h in
WT than in KOmice (Fig. 2). Interestingly, the recovery from
hypotension was quicker and more complete inWTmice than
mice with Kir6.1 deleted globally and in VSM and this was
reflected in the clear survival advantage for WT mice com-
pared with their KO counterparts. Conversely, smKO mice
had a survival advantage over their gKO counterparts suggest-
ing that perhaps KATP channels in other tissues have an im-
portant role in the response to endotoxemia.
Endotoxic shock can lead to dysfunction of major organs
and myocardial depression is a well-recognised manifestation
of this. Given that the myocardial depression seen in gKO
mice has been attributed to the VSM KATP channel, we inves-
tigated the specific role of these ion channels in response to
endotoxic challenge in VSM. Consistent with this idea, smKO
mice also have markedly reduced cardiac performance—EF,
FS and FAC were markedly reduced. The level of cardiac
dysfunction in these mice was striking with EF at ~ 20% com-
pared with ~ 70% forWTwith an LPS insult. Cardiac function
was not adversely affected in WT mice following a low-dose
LPS challenge—this was not unexpected as the effects of LPS
and even CLP on cardiac function have been shown to be dose
and time dependent in mice [10, 17, 21, 24]. We expected a
less severe cardiac phenotype given LPS-treated gKO mice
are clearly at a survival disadvantage compared with smKO
mice. We have previously shown that endothelial KATP chan-
nels are protective in metabolically challenging conditions so
it may be that the absence of endothelial KATP channels may
contribute to the gKO phenotype [15]. However,
Fig. 6 Cardiac function is preserved in eKO mice following LPS
administration. a Mean body temperature and echocardiography
parameter measurements from eKO mice and their littermate controls
18 h post-LPS injection (2 mg/kg I.P). Ejection fraction (EF), fractional
shortening (FS), left ventricular end-diastolic volume (LVEDP) and left
ventricular internal diameter (LVID) were derived from short-axis M-
mode images. Fractional area change (FAC) was measured from short-
axis B-mode images (n = 4–6 mice for each group). b Levels of circulat-
ing markers for kidney (urea and creatinine) and liver (ALT-alanine
acetyltransferase) damage in the blood of eKO mice and their littermate
controls (n = 6 mice for each group). Data is shown as mean ± S.E.M,
P > 0.05 (unpaired Student’s t test)
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echocardiography on eKO mouse hearts (Kir6.1 deleted in
endothelium) exhibited less functional signs of cardiac depres-
sion compared with smKO mice. Thus, KATP populations
containing Kir6.1 in immune cells, heart cells or neurones
may underlie the more severe phenotype seen in the global
KO mice and this is a topic for future investigation.
In sepsis patients with depressed ejection fraction, LVEDV
was found to be increased and LV dilatation was prominent [25].
These parameters were also significantly elevated in the smKO
Fig. 7 LPS-induced changes in myocardial metabolomic profile in
smKO mice. Metabolomic analysis was carried out using high-
resolution 1H NMR spectroscopy. a Representative spectra from 1H
NMR analysis of WT (top panel) and smKO (lower panel) hearts. b
Mean fold change in metabolite levels in smKO hearts compared with
WT littermate controls (n = 5–7 mice for each group). Data is shown as
mean ± SEM, **P < 0.01, ***P < 0.001 (unpaired Student’s t test)
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mice compared with WT mice. Data from our telemetry study
and experiments from other studies using mouse and insect
Kir6.1 KO models provide clear evidence for a protective role
of Kir6.1-containing KATP channels during endotoxic shock
[10–12]. More importantly, we show specifically that VSM
Kir6.1-dependent KATP channels contribute significantly to some
of this protection. The reduced cardiac performance, in particular
the EF of ~ 20%, in smKO mouse hearts is likely due to a
reduced LV performance as demonstrated by increased
LVEDP and reduced LVDP at a given balloon volume (Fig.
6). Starling curves show a lack of compliance in smKO hearts
due to the stiffness in the ventricular myocardium with a much
greater incremental increase in LVEDP and very little change in
LVDP compared with WT hearts. This is consistent with the
known systolic and diastolic dysfunction seen in impaired cardi-
ac function associated with sepsis [26–28].
Cardiac dysfunction and metabolism
The VSM KATP channel is a key player in the response to
changes in metabolism—increasing perfusion to vital
organs/systems in times of increased metabolic demand and
vice versa when metabolic demand is low.
Sepsis is predominantly thought of as an inflammatory dis-
ease; however, recent research suggests important contribu-
tions of thermoregulation, circadian rhythm and metabolism
[29]. Studies have shown that the ATP/ADP ratio is decreased
in the skeletal muscle of deceased sepsis patients and ATP is
lower in mouse and rat models in skeletal muscle and liver
[30]. This can result in a highly catabolic state [31] and hearts
from LPS-treated smKO mice demonstrated profoundly im-
paired energetics. The phosphocreatine/ATP ratio was re-
duced by ~ 50% indicative of severe metabolic impairment
as well as an increased risk of mortality [32, 33].
Additionally, TCA intermediates are also lower suggesting
enhanced TCA cycle flux as a result of higher energy demand
on LPS-treated smKO hearts. Amino acid metabolism is in-
creased as levels of some amino acids are depleted probably
due to them being used as a source for ATP production [34,
35]. The pathophysiology underlying the cardiac dysfunction
in sepsis is poorly understood [36, 37]. One feature is a con-
spicuous lack of cell death and has led to the hypothesis that
the adaptations are equivalent to the “hibernating myocardi-
um” [36–38]. This is confirmed in our control animals admin-
istered LPS but it is striking in the smKO animals that apo-
ptosis is significantly increased. A variety of mechanisms
have been invoked including endothelial dysfunction and
leakage and induction of iNOS but it is thought that mitochon-
drial dysfunction in cardiomyocytes may be key [36, 37]. In
general, coronary blood flow is normal or increased and oxy-
gen availability increased [39]. In this light, it is interesting
that endothelial KATP channel deletion does not significantly
worsen the phenotype. The heart has little reserve in terms of
oxygen delivery and any increase in demand must be accom-
panied by an increase in blood flow [40]. The mitochondrial
abnormalities are enough to ensure myocyte survival but
when metabolite and oxygen supply are compromised as in
the smKOmice, then, this results in severe metabolic compro-
mise as illustrated by our data.
Fig. 8 Schematic of the proposed protective mechanism of the vascular
KATP channel during endotoxemia. Opening of vascular KATP channels in
the coronary circulation in response to LPS-induced stress or indirectly
via vasomediators such as CGRP protects myocardial function and pre-
vents myocyte apoptosis by maintaining adequate myocardial perfusion
and metabolite provision to meet demand. An increase in metabolism and
hence ATP production in the tissues of other vascular beds ultimately
restores blood pressure homeostasis and perfusion of vital organs. The
absence of vascular KATP channels in the coronary circulation leads to a
scenario where myocardial metabolism is significantly impacted by fail-
ure of substrate delivery to the heart leading to myocyte apoptosis and
attenuated myocardial function. Blood pressure fails to recover because
of the drop in cardiac output ultimately leading to death
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Our previous work has shown the importance of VSM
KATP channels in the regulation of blood pressure, particularly
via its modulation by vasoactive mediators such as CGRP [3].
Recent work has shown that in WT LPS-treated mice block-
ade of CGRP receptors increased susceptibility to cardiac dys-
function and activation of CGRP receptors prior to infection
reduces the extent of cardiac dysfunction [17]. Thus, CGRP in
addition to specific cytokines such as TNFαmay also be a key
mediator [10]. This perhaps explains to a degree the striking
cardiac phenotype in smKO and gKO mice; however, the
discrepancy in the number of LPS-induced deaths between
smKO and gKO mice remains unexplained.
Study limitations
LPS administration is no longer thought to be a goodmodel of
complex changes that occur in sepsis [41]. LPS released from
bacteria is just one of the components contributing to the path-
ophysiological challenge. An area for future studies would be
to use other models in addition to cecal slurry such as cecal
ligation and puncture for example. Measurement of cardiac
function at multiple and earlier time points would have also
been useful to study the potential transient nature of cardiac
dysfunction in response to infection.We have previously stud-
ied the cardiovascular phenotype of these murine lines [3, 14,
15]; however, in some experiments, here we did not test under
baseline conditions (or after vehicle administration). Even
though at this age in the smKO mice we do not see a cardiac
phenotype such as hypertrophy, it is possible that the knock-
out animals may have some baseline impairment of metabo-
lism for example. Finally, more sensitive assays are now avail-
able to assess renal and liver dysfunction though the ones we
use are standard and widely available.
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